Answers are grounded in this paper and cite their sources.
Evaluation of mixed partial agonists at mu opioid and nociception receptors for pain management, suggesting new treatment options.
Opioids remain the standard of care for management of severe pain, but adverse effects limit their use, particularly for the treatment of chronic pain. Compounds that have dual partial agonist...
No takes yet. Share an insight, caveat, or question.
Ostovar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: